PRLD icon

Prelude Therapeutics

53 hedge funds and large institutions have $144M invested in Prelude Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 13 closing their positions.

Holders
53
Holders Change
-9
Holders Change %
-14.52%
% of All Funds
0.92%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
16
Reduced
20
Closed
13
Calls
$1.52M
Puts
Net Calls
+$1.52M
Net Calls Change
-$631K
Name Holding Trade Value Shares
Change
Shares
Change %
RSCM
51
Rock Springs Capital Management
Maryland
-$1.93M -368,959 Closed
Marshall Wace
52
Marshall Wace
United Kingdom
-$238K -45,716 Closed
E
53
Ergoteles
New York
-$227K -43,500 Closed
CSS
54
Cubist Systematic Strategies
Connecticut
-$208K -39,938 Closed
OQS
55
Occudo Quantitative Strategies
Florida
-$123K -23,640 Closed
Squarepoint
56
Squarepoint
New York
-$102K -19,618 Closed
SSA
57
Schonfeld Strategic Advisors
New York
-$94K -18,000 Closed
DU
58
Delphia (USA)
Ontario, Canada
-$88K -16,940 Closed
CC
59
Corton Capital
Ontario, Canada
-$81K -15,586 Closed
Ensign Peak Advisors
60
Ensign Peak Advisors
Utah
-$42K -8,080 Closed